| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-06 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
8e-05 |
| mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
9e-05 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |